Market Access for Medical Technologies in France

In mid-December 2025, a new version of the Common Classification of Medical Procedures (CCAM v.81), effective January 1, 2026, was published. Multiple changes were implemented, including the introduction of four new procedure codes, the provisional registration of four codes, the deletion of a few codes, the modification of tariffs for numerous activities/phases, and the amendment of existing services.

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the November 2025 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). One favourable opinion was issued concerning add-on reimbursement for medical device in the gastrointestinal field.

On October 21, 2025, the French National Authority for Health (HAS) issued positive opinions on the inclusion of targeted next-generation sequencing-based panels for patients with multiple myeloma and lung cancer in the NABM Nomenclature for regular reimbursement. Currently, these tests are temporarily reimbursed within the innovative payment scheme (RIHN). These HAS assessments are performed as a part of the RIHN reform and ‘cleaning up’ the List of temporarily covered tests.